White Paper: IL-18-Biomarker and Potential Therapeutic Target
Interleukin-18 (IL-18) is a critical factor in immune response, inflammation, and autoimmune disorders, making it a target in drug development and treatment. Because of IL-18's biological properties and its significant role in various diseases, it's no surprise that its involvement in the signaling pathways of many inflammatory diseases is extensively researched. Hence, drug therapies are becoming more focused on IL-18 inhibitors or agonists.
This white paper summarizes some of the properties of IL-18 and its pathological role in different diseases. Furthermore, the paper outlines therapies that target IL-18 activation and inhibition in different inflammatory diseases.
Download this White Paper to Understand:
• Biological Properties of IL-18
• Involvement in pathogenesis of some inflammatory diseases.
• Drug therapies focused on IL-18 inhibitors or agonists
After downloading this informative White Paper, contact us or review our product portfolio, to see which Il-18 products will work for you.
